$265 Million is the total value of Wildcat Capital Management, LLC's 29 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KITE | KITE PHARMA INC | $117,904,000 | +8.9% | 2,358,084 | 0.0% | 44.44% | +18.0% | |
CSGP | Sell | COSTAR GROUP INC | $55,067,000 | +15.2% | 251,837 | -0.9% | 20.75% | +24.8% |
NK | NANTKWEST INC | $27,962,000 | -24.3% | 4,495,495 | 0.0% | 10.54% | -18.0% | |
SRNE | Buy | SORRENTO THERAPEUTICS INC | $15,678,000 | +11.1% | 2,799,790 | +6.7% | 5.91% | +20.4% |
A104PS | HILTON WORLDWIDE HLDGS INC | $11,378,000 | +0.0% | 505,000 | 0.0% | 4.29% | +8.4% | |
MDXG | Buy | MIMEDX GROUP INC | $8,621,000 | +3.2% | 1,080,365 | +13.1% | 3.25% | +11.9% |
New | ISHARES TRcall | $6,880,000 | – | 61,073 | +100.0% | 2.59% | – | |
LPLA | LPL FINL HLDGS INC | $4,612,000 | -10.0% | 206,647 | 0.0% | 1.74% | -2.5% | |
CSAL | COMMUNICATIONS SALES & LEAS IN | $4,364,000 | +29.9% | 151,000 | 0.0% | 1.64% | +40.7% | |
NH | New | NANTHEALTH INC | $3,008,000 | – | 240,648 | +100.0% | 1.13% | – |
New | ISHARES TRput | $2,279,000 | – | 27,164 | +100.0% | 0.86% | – | |
New | ISHARES TRput | $1,552,000 | – | 13,580 | +100.0% | 0.58% | – | |
EDIT | Sell | EDITAS MEDICINE INC | $1,459,000 | -83.0% | 59,800 | -75.9% | 0.55% | -81.5% |
Sell | ISHARES TRcall | $1,243,000 | -52.6% | 4,830 | -51.9% | 0.47% | -48.7% | |
New | SPDR S&P 500 ETF TRcall | $864,000 | – | 4,126 | +100.0% | 0.33% | – | |
DXJ | New | WISDOMTREE TRjapn hedge eqt | $776,000 | – | 20,000 | +100.0% | 0.29% | – |
TLT | New | ISHARES TR20 yr tr bd etf | $669,000 | – | 4,832 | +100.0% | 0.25% | – |
NTLA | New | INTELLIA THERAPEUTICS INC | $534,000 | – | 25,000 | +100.0% | 0.20% | – |
New | ISHARES TRput | $445,000 | – | 3,958 | +100.0% | 0.17% | – | |
ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $47,000 | – | 15,000 | +100.0% | 0.02% | – |
COT | Exit | COTT CORP QUE | $0 | – | -839 | -100.0% | -0.00% | – |
DHX | Exit | DHI GROUP INC | $0 | – | -15,605 | -100.0% | -0.04% | – |
Exit | BLACKROCK CAPITAL INVESTMENT | $0 | – | -13,671 | -100.0% | -0.04% | – | |
FB | Exit | FACEBOOK INC-Acl a | $0 | – | -6,163 | -100.0% | -0.24% | – |
CMCSA | Exit | COMCAST CORP-CLASS Acl a | $0 | – | -11,835 | -100.0% | -0.25% | – |
AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -235,264 | -100.0% | -0.42% | – |
GSBD | Exit | GOLDMAN SACHS BDC INC | $0 | – | -100,000 | -100.0% | -0.68% | – |
NMFC | Exit | NEW MTN FIN CORP | $0 | – | -179,278 | -100.0% | -0.79% | – |
ARCC | Exit | ARES CAPITAL CORP | $0 | – | -175,000 | -100.0% | -0.90% | – |
TACO | Exit | DEL TACO RESTAURANTS INC | $0 | – | -326,478 | -100.0% | -1.17% | – |
Exit | BARCLAYS BK PLCput | $0 | – | -336,600 | -100.0% | -2.06% | – | |
Exit | SPDR S&P 500 ETF TRput | $0 | – | -106,800 | -100.0% | -7.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-12-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
NANTKWEST INC | 17 | Q3 2019 | 22.0% |
SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-04-08 |
SC 13G | 2024-04-08 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-09 |
PX14A6G | 2023-11-03 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-07 |
SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.